ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Gross margin 2017–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) gross margin by fiscal year — reported gross profit divided by reported revenue.
74.2%FY2025 · since FY2017: 59.2% → 74.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 74.2% | +14.5 pp |
| FY2024 | 59.7% | +4.1 pp |
| FY2023 | 55.6% | -13.1 pp |
| FY2022 | 68.7% | +0.7 pp |
| FY2021 | 68.1% | -9.0 pp |
| FY2020 | 77.1% | +3.3 pp |
| FY2019 | 73.8% | +9.2 pp |
| FY2018 | 64.7% | +5.4 pp |
| FY2017 | 59.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice